The UK has begun to use medications to treat COVID-19 instances before they become serious

People in the UK who are at increased risk of COVID-19 can now participate in the study of the first antiviral tablet for this virus that can be taken at home, while those who are classified as particularly susceptible can receive antibody infusions as soon as they test positive. Doctors had no therapies for COVID-19… Read More The UK has begun to use medications to treat COVID-19 instances before they become serious

South Korea approves emergency use of Pfizer’s coronavirus antiviral pill

South Korea authorised for emergency use Pfizer’s antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety said on Monday. South Korea restored tough distancing curbs last week after easing them in November, after a series of record daily new infections and… Read More South Korea approves emergency use of Pfizer’s coronavirus antiviral pill

Pfizer signs $5.3billion U.S. deal for supply of ten million courses of coronavirus antiviral pill

Pfizer Inc said on Thursday it had signed a $5.29 billion deal with the U.S. government to deliver 10 million courses of its experimental COVID-19 antiviral drug, as the country rushes to secure promising oral treatments for the disease. The deal is roughly twice the size of the contract the U.S. government has with Merck… Read More Pfizer signs $5.3billion U.S. deal for supply of ten million courses of coronavirus antiviral pill

Pfizer says its antiviral pill cuts risk of severe coronavirus by 89%

Pfizer Inc’s experimental antiviral pill to treat COVID-19 cut by 89% the chance of hospitalization or death for adults at risk of severe disease, the company said on Friday, as its CEO vowed to make this promising new weapon in the fight against the pandemic available globally as quickly as possible. The trial’s results suggest… Read More Pfizer says its antiviral pill cuts risk of severe coronavirus by 89%

South Korea to purchase seventy thousand courses of Pfizer coronavirus antiviral pill

South Korea has agreed to buy 70,000 courses of Pfizer Inc’s experimental antiviral COVID-19 pill, the Korea Disease Control and Prevention Agency (KDCA) said on Saturday. Pfizer on Friday said trial results showed that its Paxlovid pill reduced by 89% the risk of hospitalization or death in patients at high risk of severe illness within… Read More South Korea to purchase seventy thousand courses of Pfizer coronavirus antiviral pill

Britain approves use of Merck’s coronavirus antiviral pill

Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic. Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, for use in people with mild to moderate… Read More Britain approves use of Merck’s coronavirus antiviral pill